NEW YORK (GenomeWeb News) — Applied Microarrays has acquired GE Healthcare’s CodeLink microarrays and has been selling the tools since May 1, GenomeWeb Daily News has learned.
According to GE Healthcare’s Web site, as of May 1 all pre-arrayed CodeLink products, including human, mouse, and rat whole-genome arrays, will be sold through Applied Microarrays.
GE Healthcare will continue to sell CodeLink’s non-arrayed activated slides and related reagents, GE said.
According to GenomeWeb Daily News sister publication BioArray News, GE Healthcare last December told its customers it would discontinue that end of the business by April.
It was not immediately clear whether Applied Microarrays is a new company formed exclusively to take over CodeLink’s array divisions. Currently, CodeLink product information on Applied Microarray’s website link back to GE Healthcare’s site.
According to its Web site, “Our team has been formed from experts who developed the CodeLink platform and the specialized high throughput / high quality manufacturing tools.”
Applied Microarrays also specializes in contract manufacturing of custom microarrays “of all types,” partnering with customers on array content and assay optimization.
The company is based on the Arizona State University Macrotechnology Works site in Tempe.